Siao‐Yi Wang

947 total citations
12 papers, 685 citations indexed

About

Siao‐Yi Wang is a scholar working on Immunology, Radiology, Nuclear Medicine and Imaging and Oncology. According to data from OpenAlex, Siao‐Yi Wang has authored 12 papers receiving a total of 685 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Immunology, 5 papers in Radiology, Nuclear Medicine and Imaging and 3 papers in Oncology. Recurrent topics in Siao‐Yi Wang's work include Monoclonal and Polyclonal Antibodies Research (5 papers), Immune Cell Function and Interaction (4 papers) and CAR-T cell therapy research (3 papers). Siao‐Yi Wang is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (5 papers), Immune Cell Function and Interaction (4 papers) and CAR-T cell therapy research (3 papers). Siao‐Yi Wang collaborates with scholars based in United States. Siao‐Yi Wang's co-authors include George J. Weiner, Emilian Racila, Ronald P. Taylor, Brian K. Link, Suresh Veeramani, J. A. Bowles, Barrett W. Allan, Gregory Beuerlein, Brian J. Smith and James E. Wooldridge and has published in prestigious journals such as Blood, PLoS ONE and Scientific Reports.

In The Last Decade

Siao‐Yi Wang

12 papers receiving 664 citations

Peers

Siao‐Yi Wang

IMMUN

RNMI

ONCOL

GENET

Massimiliano Manganini Italy

Patrick F. Joyce United States

Bart E.C.G. de Goeij Netherlands

Erik Pong United States

Nicolas Leupin Switzerland

Emanuela Carlotti United Kingdom

Máté Tolnay United States

Debora Pezzuolo Italy

Laki Buluwela United Kingdom

Massimiliano Manganini Italy

Siao‐Yi Wang

294 ×0.8

IMMUN

229 ×0.7

RNMI

223 ×1.1

ONCOL

186 ×1.1

216 ×1.6

GENET

Citations per year, relative to Siao‐Yi Wang Siao‐Yi Wang (= 1×) peers Massimiliano Manganini

Countries citing papers authored by Siao‐Yi Wang

Since Specialization

Citations

This map shows the geographic impact of Siao‐Yi Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Siao‐Yi Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Siao‐Yi Wang more than expected).

Fields of papers citing papers by Siao‐Yi Wang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Siao‐Yi Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Siao‐Yi Wang. The network helps show where Siao‐Yi Wang may publish in the future.

Co-authorship network of co-authors of Siao‐Yi Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Siao‐Yi Wang. A scholar is included among the top collaborators of Siao‐Yi Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Siao‐Yi Wang. Siao‐Yi Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

Wang, Siao‐Yi, et al.. (2023). Nonactivated and IL-7 cultured CD19-specific CAR T cells are enriched in stem cell phenotypes and functionally superior. Blood Advances. 8(2). 324–335. 8 indexed citations

Moore, Tamson V., Gina Scurti, Siao‐Yi Wang, et al.. (2021). HDAC inhibition prevents transgene expression downregulation and loss-of-function in T cell-receptor-transduced T cells. Molecular Therapy — Oncolytics. 20. 352–363. 7 indexed citations

Wang, Siao‐Yi, et al.. (2021). Melanoma reactive TCR-modified T cells generated without activation retain a less differentiated phenotype and mediate a superior in vivo response. Scientific Reports. 11(1). 13327–13327. 7 indexed citations

Schrock, Alexa B., Russell W. Madison, Mark R. Rosenzweig, et al.. (2020). <p>Patients with NSCLCs Harboring Internal Inversions or Deletion Rearrangements of the <em>ALK</em> Gene Have Durable Responses to ALK Kinase Inhibitors</p>. PubMed. Volume 11. 33–39. 1 indexed citations

Wang, Siao‐Yi, Stephen Shiboski, Cassandra D. Belair, et al.. (2014). miR-19, miR-345, miR-519c-5p Serum Levels Predict Adverse Pathology in Prostate Cancer Patients Eligible for Active Surveillance. PLoS ONE. 9(6). e98597–e98597. 46 indexed citations

Wang, Siao‐Yi, Janet E. Cowan, K. Clint Cary, et al.. (2013). Limited ability of existing nomograms to predict outcomes in men undergoing active surveillance for prostate cancer. British Journal of Urology. 114(6b). E18–E24. 37 indexed citations

Veeramani, Suresh, Siao‐Yi Wang, Christopher E. Dahle, et al.. (2011). Rituximab infusion induces NK activation in lymphoma patients with the high-affinity CD16 polymorphism. Blood. 118(12). 3347–3349. 96 indexed citations

Wang, Siao‐Yi, et al.. (2009). Depletion of the C3 component of complement enhances the ability of rituximab-coated target cells to activate human NK cells and improves the efficacy of monoclonal antibody therapy in an in vivo model. Blood. 114(26). 5322–5330. 105 indexed citations

Wang, Siao‐Yi & George J. Weiner. (2008). Complement and cellular cytotoxicity in antibody therapy of cancer. Expert Opinion on Biological Therapy. 8(6). 759–768. 61 indexed citations

10.

Wang, Siao‐Yi, Emilian Racila, Ronald P. Taylor, & George J. Weiner. (2007). NK-cell activation and antibody-dependent cellular cytotoxicity induced by rituximab-coated target cells is inhibited by the C3b component of complement. Blood. 111(3). 1456–1463. 144 indexed citations

11.

Bowles, J. A., Siao‐Yi Wang, Brian K. Link, et al.. (2006). Anti-CD20 monoclonal antibody with enhanced affinity for CD16 activates NK cells at lower concentrations and more effectively than rituximab. Blood. 108(8). 2648–2654. 171 indexed citations

12.

Wang, Siao‐Yi, Emilian Racila, Ronald P. Taylor, & George J. Weiner. (2006). The C3b Component of Complement Inhibits NK Cell Activation Induced by Rituximab-Coated Target Cells.. Blood. 108(11). 2505–2505. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact